Xiangjie Lin

The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019

Yiyi Yao, Xiangjie Lin, Fenglin Li et al. · BioMedical Engineering OnLine · 2022 · 80 citations · Full text

Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitors

Gregory D. Cuny, Natalia P. Ulyanova, Debasis Patnaik et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 72 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Drug Target +10

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia

Wenyan Cheng, Jianfeng Li, Yongmei Zhu et al. · Proceedings of the National Academy of Sciences · 2022 · 59 citations · Full text

Structure–activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors

Gregory D. Cuny, Maxime Robin, Natalia P. Ulyanova et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 57 citations · Full text

Molecular Pharmacology, Drug Target, Biochemistry +13

FePt-Cys nanoparticles induce ROS-dependent cell toxicity, and enhance chemo-radiation sensitivity of NSCLC cells in vivo and in vitro

Yingming Sun, Hongtao Miao, Shijing Ma et al. · Cancer Letters · 2018 · 47 citations

Nanoparticles, Engineering, Nsclc Cells +9